Quick Answer
Lucid Diagnostics Inc. reported Stockholders Equity of $10.94 million for fiscal year 2025.
Lucid Diagnostics Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $10.94M | +102.9% |
| 2024 | $5.39M | +333.3% |
| 2023 | -$2.31M | -110.0% |
| 2022 | $23.05M | -57.9% |
| 2021 | $54.74M | +504.9% |
| 2020 | -$13.52M | -154.6% |
| 2019 | -$5.31M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $25.84M | +307.6% | +228.6% |
| June 30, 2025 | $7.86M | -50.8% | +246.2% |
| March 31, 2025 | -$5.38M | -145.2% | -199.7% |
| December 31, 2024 | $5.39M | +333.3% | -14.9% |
| September 30, 2024 | $6.34M | +148.0% | -60.3% |
| June 30, 2024 | $15.98M | +6.0% | +34.3% |
| March 31, 2024 | $11.89M | -52.2% | +614.7% |
| December 31, 2023 | -$2.31M | -110.0% | -190.4% |
- Lucid Diagnostics Inc. showed an increase of +102.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Lucid Diagnostics Inc.’s stockholders equity has grown by 306.0% (from -$5.31 million to $10.94 million).
- The most recent figure is from Lucid Diagnostics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: